Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
inactivated influenza vaccine (1 trial)
pneumococcal 7-valent conjugate vaccine (Prevnar) (1 trial)
Influenza, Human (Phase 4)
Pneumococcal Infections (Phase 3)
Pneumonia (Phase 3)
Trials (2 total)
Trial APIs (2 total)